✦ LIBER ✦

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

✍ Scribed by Prins, Martin H; Lensing, Anthonie WA; Bauersachs, Rupert; van Bellen, Bonno; Bounameaux, Henri; Brighton, Timothy A; Cohen, Alexander T; Davidson, Bruce L; Decousus, Hervé; Raskob, Gary E; Berkowitz, Scott D; Wells, Philip S

Book ID: 121618210
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 200 KB
Volume: 11
Category: Article
ISSN: 1477-9560
DOI: 10.1186/1477-9560-11-21

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RIVAROXABAN FOR THE TREATMENT OF SYMPTOM

RIVAROXABAN FOR THE TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM: IS THERE A NEED FOR INITIAL HEPARIN TREATMENT? A SUBGROUP ANALYSIS OF THE EINSTEIN DVT AND PE STUDIES

✍ Lensing, Anthonie W.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Rivaroxaban for the treatment of symptom

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies

✍ Wang, Yuqi; Wang, Chen; Chen, Zhong; Zhang, Jiwei; Liu, Zhihong; Jin, Bi; Ying, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 183 KB

Efficiency and effectiveness of the use

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial

✍ Antonio J Carcas, Alberto M Borobia, Marta Velasco, Francisco Abad-Santos, Manue 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 330 KB